Effects of canagliflozin on cardiovascular biomarkers in older adults with type 2 diabetes
Background Sodium glucose co-transporter 2 inhibitors may reduce cardiovascular and
heart failure risk in patients with type 2 diabetes mellitus (T2DM). Objectives The goal of this …
heart failure risk in patients with type 2 diabetes mellitus (T2DM). Objectives The goal of this …
Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes
JL Januzzi Jr, J Butler, P Jarolim, N Sattar, U Vijapurkar… - 2017 - pubmed.ncbi.nlm.nih.gov
Background Sodium glucose co-transporter 2 inhibitors may reduce cardiovascular and
heart failure risk in patients with type 2 diabetes mellitus (T2DM). Objectives The goal of this …
heart failure risk in patients with type 2 diabetes mellitus (T2DM). Objectives The goal of this …
[HTML][HTML] Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes
JL Januzzi Jr, J Butler, P Jarolim, N Sattar… - Journal of the American …, 2017 - Elsevier
Background Sodium glucose co-transporter 2 inhibitors may reduce cardiovascular and
heart failure risk in patients with type 2 diabetes mellitus (T2DM). Objectives The goal of this …
heart failure risk in patients with type 2 diabetes mellitus (T2DM). Objectives The goal of this …
Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes.
JL Januzzi Jr, J Butler, P Jarolim, N Sattar… - Journal of the …, 2017 - europepmc.org
Background Sodium glucose co-transporter 2 inhibitors may reduce cardiovascular and
heart failure risk in patients with type 2 diabetes mellitus (T2DM). Objectives The goal of this …
heart failure risk in patients with type 2 diabetes mellitus (T2DM). Objectives The goal of this …
Effects of canagliflozin on cardiovascular biomarkers in older adults with type 2 diabetes
JL Januzzi, J Butler, P Jarolim, N Sattar… - Journal of the …, 2017 - eprints.gla.ac.uk
Background: Sodium glucose co-transporter 2 (SGLT2) inhibitors may reduce
cardiovascular and heart failure risk in patients with type 2 diabetes mellitus (T2DM) …
cardiovascular and heart failure risk in patients with type 2 diabetes mellitus (T2DM) …
[引用][C] Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes
JL Januzzi, J Butler, P Jarolim, N Sattar… - Journal of the American …, 2017 - cir.nii.ac.jp